UBS Maintains Neutral on Gentex, Lowers Price Target to $24

Benzinga Newsdesk www.benzinga.com Negative 88.2%

Neg 88.2% Neu 0% Pos 0%

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $25 to $24.

Comments

No comments yet. Be the first!